Citations

Showing 10 of 108152 citations.

Regression of mycosis fungoides with large‐cell transformation following skin biopsy
Besch‐Stokes, Jake , Costello, Collin M. , Bhullar, Puneet , Maly, Connor , DiCaudo, David J. , Pittelkow, Mark R. , Mangold, Aaron R. , Besch-Stokes, J G , Mangold, A R , Costello, Collin M , Rosenthal, Allison

Mayo Clinic

Journal of the European Academy of Dermatology and Venereology | October 1, 2019 | Volume: 34 | Issue: 2 | Pages: No page available

10.1111/jdv.15976 | PMID 31566801 Get It

Patient Safety/Quality Improvement Primer, Part II: Prevention of Harm Through Root Cause Analysis and Action (RCA2)
Balakrishnan, Karthik , Brenner, Michael , Gosbee, John, Schmalbach, Cecelia E. , Balakrishnan, Karthik

Mayo Clinic

Otolaryngology–Head and Neck Surgery | October 1, 2019 | Volume: 161 | Issue: 6 | Pages: 911-921

10.1177/0194599819878683 | PMID 31570058 Get It

With increasing emphasis on patient safety/quality improvement, health care systems are mirroring industry in the implementation of root cause analysis (RCA) for the identification and mitigation of errors. RCA uses a team approach with emphasis on the system, as opposed to the individual, to accrue empirical data on what happened and why. While many otolaryngologists have a broad understanding of RCA, practical experience is often lacking. Part II of this patient safety/quality improvement primer investigates the manner in which RCA is utilized in the prevention of medical errors. Attention is given to identifying system errors, recording adverse events, and determining which events warrant RCA. The primer outlines steps necessary to conduct an effective RCA, with emphasis placed on actions that arise from the RCA process through the root cause analysis and action (or RCA2) rubric. In addition, the article provides strategies for the implementation of RCA into clinical practice and medical education.
A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women
Bruce, Alison J., Pincelli, Thaís , Desmond, Cheryl M., Arthurs, Jennifer R. , Diehl, Nancy N. , Douglass, Erika J. , Pincelli, Thais P, Pincelli, T , Heckman, Michael G. , Bruce, Charles J. , Shapiro, Shane A.

Mayo Clinic

Dermatologic Surgery | October 1, 2019 | Volume: 46 | Issue: 6 | Pages: 826-832

10.1097/dss.0000000000002168 | PMID 31574029 Get It

BACKGROUNDAndrogenic alopecia (AGA) is a common hair loss disorder. Studies have demonstrated successful treatment with platelet-rich plasma (PRP) in men, but studies in women are few.OBJECTIVETo evaluate PRP in the treatment of AGA in women, compared with topical minoxidil.MATERIALS AND METHODSTwenty women with AGA received topical minoxidil for 12 weeks and injectable PRP for 12 weeks in a randomized crossover design with an 8-week washout between treatments. Standardized TrichoScan analysis and quality-of-life questionnaires were assessed at baseline and 12-week follow-up for each treatment.RESULTSAfter PRP, significant increases from baseline to Week 12 in TrichoScan analysis hair count (p= .002) and vellus hair density (p= .009) occurred. However, minoxidil resulted in significant increases in hair count (p< .001), vellus hair density (p= .03), terminal hair density (p= .004), and cumulative thickness (p= .004). Several quality of life responses improved from baseline to Week 12 after PRP treatment, whereas no improvements were noted after minoxidil.CONCLUSIONPlatelet-rich plasma is an effective treatment for hair regrowth in female AGA, although not as effective as minoxidil. However, the improved quality of life responses after PRP, but not minoxidil, suggest a potential overall greater degree of satisfaction with PRP.LEVELS OF EVIDENCEI.CLINICAL TRIAL REGISTRATIONNCT03488108.
Dysphonia Due to Vocal Cord Injury After Rigid Bronchoscopy
Youssef, Stephanie J. , Orbelo, Diana M. , Sakata, Kenneth K. , Zimmermann, Terence M., Pittelko, Rebecca L. , Nelson, Darlene R. , Midthun, David E. , Edell, Eric S. , Ekbom, Dale C. , Orbelo, Diana

Mayo Clinic

Journal of Bronchology & Interventional Pulmonology | October 1, 2019 | Volume: 26 | Issue: 4 | Pages: e52-e55

10.1097/lbr.0000000000000587 | PMID 31569103 Get It

Reaction to Clindamycin Causing Laryngitis and Esophagitis
Rutt, Amy L. , Wang, Charis , Wang, Charis E, Rutt, Amy L.

Mayo Clinic

Ear, Nose & Throat Journal | October 1, 2019 | Volume: 100 | Issue: 6 | Pages: 437-438

10.1177/0145561319875138 | PMID 31569974 Get It

Parotid Gland Mass as an Initial Manifestation of Oropharyngeal Carcinoma
Dowling, Eric M. , Janus, Jeffrey R. , Dowling, Eric M.

Mayo Clinic

Ear, Nose & Throat Journal | October 1, 2019 | Volume: 100 | Issue: 5 | Pages: NP246-NP247

10.1177/0145561319869609 | PMID 31569975 Get It

Acellular Dermal Matrix Performance Compared with Latissimus Dorsi Myocutaneous Flap in Expander-Based Breast Reconstruction
Patrinely, James R. , Farinas, Angel F. , Al-Majed, Bader, Forte, Antonio J. , TerKonda, Sarvam P. , TerKonda, Sarvam , Forte, Antonio Jorge , Perdikis, Galen

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | October 1, 2019 | Volume: 7 | Issue: 9 | Pages: e2414

10.1097/gox.0000000000002414 | PMID 31942389 Get It

Background: Latissimus dorsi myocutaneous flap (LDMF) with tissue expander provides excellent results in breast reconstruction. Acellular dermal matrix (ADM) has been used in expander-based reconstruction (EBR) with good results. This study assesses how ADM compares to LDMF in EBR. Methods: The cohorts comprised 124 patients (218 breasts) who had EBR using ADM between 2006 and 2012, and 242 patients (266 breasts) who had EBR using LDMF between 1994 and 2012. Postoperative complications, reoperations, Breast-Q scores, and objectively assessed aesthetic outcomes were compared. Results: Median age was 55 years for both ADM (range 23–84) and LDMF (range 26–88) groups. No statistically significant differences were noted between the groups in the rates of major postoperative complications (P > 0.3). Forty-nine of the 218 (22.5%) in the ADM group and 67 of 266 (25.2%) in the LDMF group had a total of 63 and 84 reoperations, respectively (P = 0.52), with no significant differences in the reoperations rate (P > 0.3). No significant differences were observed in the Breast-Q scores. Some categorical differences were noted in the aesthetic outcomes; however, the difference between the overall outcomes was not significant (P = 0.54). Conclusion: Our study revealed no statistically significant differences in the complications or reoperation rates, patient satisfaction, or overall aesthetic outcomes when comparing the use of ADM to LDMF in EBR. In conclusion, this study supports the hypothesis that ADM performs as well as LDMF in EBR.
Identification of novel, immune-mediating extracellular vesicles in human lymphatic effluent draining primary cutaneous melanoma
Maus, Rachel L.G., Jakub, James W. , Nevala, Wendy K. , Christensen, Trace , Sutor, Shari L., Flotte, Thomas J. , Christensen, Trace A, Jakub, James W , Hieken, Tina J. , Markovic, Svetomir N.

Mayo Clinic

OncoImmunology | September 30, 2019 | Volume: 8 | Issue: 12 | Pages: No page available

10.1080/2162402x.2019.1667742 | PMID 31741769 Get It